Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial

Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial

<p><strong>Background</strong></p> Typhoid fever remains a major cause of morbidity and mortality in low-income and middle-income countries. Vi-tetanus toxoid conjugate vaccine (Vi-TT) is recommended by WHO for implementation in high-burden countries, but there is little evid...

Full description

Bibliographic Details
Main Authors:	Qadri, F, Khanam, F, Liu, X, Theiss-Nyland, K, Biswas, PK, Bhuiyan, AI, Ahmmed, F, Colin-Jones, R, Smith, N, Tonks, S, Voysey, M, Mujadidi, YF, Mazur, O, Rajib, NH, Hossen, MI, Ahmed, SU, Khan, A, Rahman, N, Babu, G, Greenland, M, Kelly, S, Ireen, M, Islam, K, O'Reilly, P, Scherrer, KS, Pitzer, VE, Neuzil, KM, Zaman, K, Pollard, AJ, Clemens, JD
Format:	Journal article
Language:	English
Published:	Elsevier 2021

Similar Items

Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh
by: Khanam, F, et al.
Published: (2023)

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
by: Essie Komla, et al.
Published: (2021-06-01)

Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV)
by: Voysey, M, et al.
Published: (2018)

Erythema multiforme induced by tetanus toxoid vaccine
by: Deepa Chaudhary, et al.
Published: (2020-01-01)

Post-exposure vaccination with tetanus toxoid alone, does not protect against tetanus: an illustrative case
by: Sunitha B, et al.
Published: (2016-04-01)

Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys
by: Rui Yu, et al.
Published: (2016-06-01)

Current state of methods for control the safety and potency of diphtheria toxoid and tetanus toxoid in combined vaccines
by: E. I. Komarovskaya, et al.
Published: (2022-07-01)

Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan
by: Kharabsheh Saad, et al.
Published: (2001-01-01)

Maternal tetanus toxoid vaccination and neonatal mortality in rural north India.
by: Abhishek Singh, et al.
Published: (2012-01-01)

Efficacy of Freeze Dried Inactivated Equine Influenza, Equine Herpesvirus-1 and Tetanus Toxoid Vaccine
by: Nashwa K. Madkour, et al.
Published: (2023-06-01)

Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis
by: Khanam, F, et al.
Published: (2023)

Maternal Tetanus Toxoid Vaccination in Benin: Evidence from the Demographic and Health Survey
by: Daniel Amoak, et al.
Published: (2022-12-01)

Awareness and Uptake of Tetanus Toxoid Vaccination Among Females of Reproductive Age in Rawalpindi
by: Shumaila Humayun, et al.
Published: (2023-04-01)

Transcriptomic response of porcine PBMCs to vaccination with tetanus toxoid as a model antigen.
by: Marcel Adler, et al.
Published: (2013-01-01)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
by: Vivek Kumar, et al.
Published: (2018-01-01)

Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children
by: Sung-Hsi Wei, et al.
Published: (2011-02-01)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
by: Ammar Hussam
Published: (2011-10-01)

Trials For Preparation Of Combined Vaccine Of Equine Influenza, Equine Herpesvirus–1, Rabies Virus And Tetanus Toxoid
by: Safaa A. Warda, et al.
Published: (2021-01-01)

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine
by: Beatriz Quiambao, et al.
Published: (2020-06-01)

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
by: Hitt J Sharma, et al.
Published: (2023-12-01)

Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines
by: Davide Oldrini, et al.
Published: (2023-11-01)

CD154 Expression Indicates T Cell Activation Following Tetanus Toxoid Vaccination of Horses
by: Christiane L. Schnabel, et al.
Published: (2022-04-01)

Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda.
by: Fredrick Makumbi, et al.
Published: (2018-01-01)

A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen
by: Olga Ticha, et al.
Published: (2021-06-01)

Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model
by: Donia Alson, et al.
Published: (2020-05-01)

Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus
by: Deming Michael S., et al.
Published: (2002-01-01)

Assessment of the Vaccination Status of Pregnant Mothers and their Infants after Birth with Tetanus Toxoid in District Rawalpindi of Pakistan
by: Ayub Jadoon, et al.
Published: (2016-01-01)

Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents
by: Beatriz P. Quiambao, et al.
Published: (2017-03-01)

Assessing immune competence in pigs by immunization with tetanus toxoid
by: U. Gimsa, et al.
Published: (2018-01-01)

Increasing Frequency of Antenatal Care Visits May Improve Tetanus Toxoid Vaccination Coverage in Pregnant Women in Pakistan
by: Sehar Iqbal, et al.
Published: (2020-07-01)

Effect of cash incentives on tetanus toxoid vaccination among rural Nigerian women: a randomized controlled trial
by: Ryoko Sato, et al.
Published: (2020-05-01)

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
by: Markus Knuf, et al.
Published: (2022-11-01)

Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay
by: Thomas J. M. Michiels, et al.
Published: (2020-12-01)

Evaluation of Potency on Diphtheria and Tetanus Toxoid for Adult Vaccines by In Vivo Toxin Neutralization Assay Using National Reference Standards
by: Chan Woong Choi, et al.
Published: (2018-10-01)

Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein – conjugated pneumococcal vaccine in Filipino infants
by: Käyhty Helena, et al.
Published: (2003-08-01)

The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh.
by: Tanvir Abir, et al.
Published: (2017-01-01)

Rapid method using high performance liquid chromatography for the purification of tetanus toxoid
by: I. A. F. B. Silveira, et al.
Published: (1994-12-01)

Evaluation of the immune response to diphtheria and tetanus toxoids by the serological methods
by: Е. I. Komarovskaya, et al.
Published: (2023-10-01)

Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infection among Bangladeshi children: A protocol for a phase IIIb trial
by: Theiss-Nyland, K, et al.
Published: (2019)

The absence of iron deficiency effect on the humoral immune response of piglets to tetanus toxoid
by: M. Svoboda, et al.
Published: (2007-05-01)